Pure Biologics EBITDA per Employee

EBITDA per Employee of Pure Biologics is -227,811.32 PLN in 2026.

EBITDA per Employee of Pure Biologics changed from -489,566.04 PLN to -227,811.32 PLN, representing a -53.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Pure Biologics since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Pure Biologics historically and in real time.